The Ohio State Comprehensive Cancer Center is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
The Ohio State Comprehensive Cancer Center has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Myelodysplastic Syndromes, Low Grade Serous Carcinoma, COVID-19.
Sponsors: Geron Corporation, Gynecologic Oncology Group, Telios Pharma, Inc..
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State Comprehensive Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State Comprehensive Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Myelodysplastic Syndromes, Low Grade Serous Carcinoma, COVID-19.
The Ohio State Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.